坎伯兰药业 CPIX 深 沪
已收盘 12-12 16:00:00 美东时间
2.53
+0.040
+1.61%
华盛通- 最 高2.66
- 今 开2.51
- 成交量 10.26万股
- 最 低 2.4192
- 昨 收 2.49
- 总市值 3784.02万
- 52周最高 7.25
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.85
- 委 比 -36.02%
- 总股本 1495.66万
- 历史最高 8.02
- 量 比 0.70
- 振 幅 9.67%
- 历史最低 1.04
- 每 手 1
- 风险率 1.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cumberland's Caldolor Injection Receives Permanent J-Code With Reimbursement
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), today announced an important update regarding its Caldolor® (ibuprofen) Injection. The product's permanent J-code, J1741, is now officially associated with a
12-08 22:11
RedHill Biopharma Successfully Regains Compliance with Nasdaq Stockholders' Equity Requirement
TEL-AVIV, Israel and RALEIGH, N.C., Dec. 1, 2025 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced th...
12-01 20:00
Cumberland Pharmaceuticals Reports Revenue Growth and Strategic Expansions
Cumberland Pharmaceuticals Inc. ( ($CPIX) ) has released its Q3 earnings. Here ...
11-05 12:59
Cumberland Q3 Adj. EPS $(0.06) Down From $(0.02) YoY, Sales $8.292M Down From $9.086M YoY
Cumberland (NASDAQ:CPIX) reported quarterly losses of $(0.06) per share. This is a 200 percent decrease over losses of $(0.02) per share from the same period last year. The company reported $8.292 million in sales this
11-05 06:01
CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH
NASHVILLE, Tenn., Nov. 4, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved ...
11-05 06:00
Earnings Scheduled For November 4, 2025
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
11-04 19:12
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE
NASHVILLE, Tenn., Oct. 28, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its third quarter 202...
10-29 04:05
RedHill Biopharma Receives Nasdaq Staff Determination Notification
On October 16, 2025, the Company received a Staff Determination notification from The Nasdaq Stock Market LLC regarding continued non-compliance with the minimum stockholders' equity require...
10-23 04:50
Cumberland Pharmaceuticals Partners with RedHill for Talicia
Cumberland Pharmaceuticals ( ($CPIX) ) just unveiled an announcement. On Octobe...
10-21 21:47
RedHill's Talicia® Secures $4 Million Strategic Investment and U.S. Co-Commercialization Partnership Deal
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) invests $4 million in exchange for a 30% ownership stake and joint control in RedHill's Talicia business U.S. co-commercialization partnership ...
10-20 21:00
